[{"bbox": [91, 98, 368, 130], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [91, 169, 1560, 232], "category": "Text", "text": "Following are the details as per the restated financial statements for the financial years ended on March 31, 2025, March 31, 2024 and March 31, 2023:"}, {"bbox": [1414, 232, 1556, 263], "category": "Text", "text": "(₹ in Lakhs)"}, {"bbox": [91, 263, 1556, 759], "category": "Table", "text": "<table><thead><tr><th rowspan=\"3\">Sr. No</th><th rowspan=\"3\">Particulars</th><th colspan=\"3\">For the period/ year ended</th></tr><tr><th>March 31, 2025</th><th>March 31, 2024</th><th>March 31, 2023</th></tr><tr><th colspan=\"3\">Consolidated</th></tr></thead><tbody><tr><td>1.</td><td>Equity Share Capital</td><td>157.50</td><td>157.50</td><td>157.50</td></tr><tr><td>2.</td><td>Net Worth</td><td>18,994.53</td><td>16,181.44</td><td>12,736.52</td></tr><tr><td>3.</td><td>Total Income</td><td>32,258.42</td><td>20,644.81</td><td>18,481.15</td></tr><tr><td>4.</td><td>Profit/(loss) after tax</td><td>2,813.09</td><td>3,444.47</td><td>3,209.71</td></tr><tr><td>5.</td><td>Earnings per Share (based on weighted average number of shares)</td><td>28.63</td><td>21.87</td><td>20.38</td></tr><tr><td>6.</td><td>Net Asset Value per Share (based on actual number of shares)</td><td>1,206.00</td><td>1,027.39</td><td>808.67</td></tr><tr><td>7.</td><td>Net Asset Value per Share (based on Weighted Average Number of Shares)</td><td>120.60</td><td>102.74</td><td>80.87</td></tr><tr><td>8.</td><td>Total Borrowings (including current maturities of long-term borrowings)</td><td>16,494.98</td><td>9,691.00</td><td>7,364.84</td></tr></tbody></table>"}, {"bbox": [91, 793, 526, 824], "category": "Section-header", "text": "## G. AUDITOR QUALIFICATIONS"}, {"bbox": [91, 857, 1244, 890], "category": "Text", "text": "There are no audit qualifications which have not been given effect in the Restated Financial Statements."}, {"bbox": [91, 920, 738, 951], "category": "Section-header", "text": "## H. SUMMARY OF OUTSTANDING LITIGATIONS"}, {"bbox": [91, 984, 1556, 1049], "category": "Text", "text": "A summary of outstanding litigations proceedings involving our Company, Promoters, Directors, KMPs, Group Company and Subsidiary Company as on the date of this Draft Red Herring Prospectus are as below:"}, {"bbox": [91, 1077, 1556, 1746], "category": "Table", "text": "<table><thead><tr><th>S. No.</th><th>Name of Entity</th><th>Criminal Proceedings</th><th>Tax Proceedings</th><th>Material Civil Litigations</th><th>Aggregate amount involved (₹ in lakhs)</th></tr></thead><tbody><tr><td rowspan=\"2\">1.</td><td><strong>Company</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Company</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Company</td><td>-</td><td>5</td><td>-</td><td>154.75</td></tr><tr><td rowspan=\"2\">2.</td><td><strong>Subsidiary</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Subsidiary</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Subsidiary</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td rowspan=\"2\">3.</td><td><strong>Promoters*</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Promoters</td><td>1</td><td>1</td><td>1</td><td>44.63</td></tr><tr><td></td><td>Against the Promoters</td><td>-</td><td>8</td><td>4</td><td>164.56</td></tr><tr><td rowspan=\"2\">4.</td><td><strong>Directors (other than Promoters)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Directors</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Directors</td><td>-</td><td>-</td><td>2</td><td>Unascertainable</td></tr><tr><td rowspan=\"2\">5.</td><td><strong>Key Managerial Personal & Senior Management</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Company</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Company</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td rowspan=\"2\">6.</td><td><strong>Group Companies (Material to our Company)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Group Companies</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Group Companies</td><td>-</td><td>6</td><td>-</td><td>360.10</td></tr></tbody></table>"}, {"bbox": [91, 1748, 1556, 1812], "category": "Text", "text": "*Includes the litigation proceedings pertain to POCT Services, a partnership firm in which our Promoters, Saurabh Garg and Amita Garg, are partners."}, {"bbox": [91, 1812, 1556, 1876], "category": "Text", "text": "For further details, please refer to the chapter titled \"Outstanding Litigations and Material Developments\" on page 257 of this Draft Red Herring Prospectus."}, {"bbox": [91, 1907, 348, 1938], "category": "Section-header", "text": "## I. RISK FACTORS"}, {"bbox": [91, 1971, 1556, 2035], "category": "Text", "text": "For details on the risks involved in our business, please see the Chapter titled \"Risk Factors\" beginning on page 29 of this Draft Red Herring Prospectus."}, {"bbox": [91, 2067, 707, 2098], "category": "Section-header", "text": "## J. SUMMARY OF CONTINGENT LIABILITIES"}, {"bbox": [1423, 2098, 1556, 2129], "category": "Text", "text": "(₹ in lakhs)"}, {"bbox": [91, 2129, 1556, 2165], "category": "Table", "text": "<table><thead><tr><th>Particulars</th><th>As at</th></tr></thead></table>"}, {"bbox": [808, 2171, 840, 2200], "category": "Page-footer", "text": "22"}]